Skip to main content
. 2025 Sep 15;19:1988. doi: 10.3332/ecancer.2025.1988

Figure 2. Typical three-dose level SIB plan for nasopharyngeal carcinoma, comparing: (a) 95% of PTV70 for VMP, (b) 95% of PTV70 for VAP, (c) colour wash – PTV56 for VMP, (d) colour wash – PTV56 for VAP and (e) DVH for VMP versus VAP showing the three PTVs and OARs.

Figure 2.